Deerfield Management Company as of June 30, 2011
Portfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 65 positions in its portfolio as reported in the June 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Walgreen Company | 8.4 | $41M | 975k | 42.46 | |
| St. Jude Medical | 7.2 | $36M | 750k | 47.68 | |
| Aetna | 6.6 | $33M | 737k | 44.09 | |
| CVS Caremark Corporation (CVS) | 5.9 | $29M | 783k | 37.58 | |
| McKesson Corporation (MCK) | 5.4 | $27M | 318k | 83.65 | |
| AmerisourceBergen (COR) | 5.2 | $26M | 625k | 41.40 | |
| Teva Pharmaceutical Industries (TEVA) | 4.9 | $24M | 500k | 48.22 | |
| Humana (HUM) | 4.4 | $22M | 271k | 80.54 | |
| Medco Health Solutions | 4.3 | $21M | 375k | 56.52 | |
| Medivation | 3.8 | $19M | 876k | 21.43 | |
| Merck & Co (MRK) | 2.9 | $14M | 400k | 35.29 | |
| Johnson & Johnson (JNJ) | 2.7 | $13M | 200k | 66.52 | |
| NuVasive | 2.7 | $13M | 405k | 32.88 | |
| CIGNA Corporation | 2.6 | $13M | 252k | 51.43 | |
| Magellan Health Services | 2.5 | $13M | 231k | 54.74 | |
| Gen-Probe Incorporated | 2.1 | $10M | 150k | 69.15 | |
| United Therapeutics Corporation (UTHR) | 1.8 | $8.8M | 160k | 55.10 | |
| Bristol Myers Squibb (BMY) | 1.8 | $8.7M | 300k | 28.96 | |
| Ardea Biosciences | 1.7 | $8.5M | 334k | 25.46 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $7.8M | 150k | 51.99 | |
| Conceptus | 1.4 | $6.8M | 580k | 11.67 | |
| Anthera Pharmaceuticals | 1.3 | $6.5M | 800k | 8.17 | |
| AngioDynamics (ANGO) | 1.1 | $5.7M | 401k | 14.23 | |
| Derma Sciences | 1.1 | $5.6M | 606k | 9.21 | |
| Amgen (AMGN) | 1.1 | $5.5M | 94k | 58.35 | |
| Abiomed | 1.1 | $5.3M | 329k | 16.20 | |
| Almost Family | 1.0 | $5.1M | 185k | 27.40 | |
| Metropolitan Health Networks | 1.0 | $4.8M | 995k | 4.79 | |
| Five Star Quality Care | 0.9 | $4.6M | 800k | 5.81 | |
| Alkermes | 0.9 | $4.7M | 250k | 18.60 | |
| Cephalon | 0.9 | $4.6M | 57k | 79.89 | |
| Triple-S Management | 0.8 | $4.0M | 186k | 21.73 | |
| Cardiovascular Systems | 0.8 | $4.0M | 273k | 14.56 | |
| Biolase Technology | 0.8 | $3.7M | 721k | 5.14 | |
| Rockwell Medical Technologies | 0.7 | $3.6M | 280k | 12.84 | |
| Salix Pharmaceuticals | 0.7 | $3.5M | 87k | 39.83 | |
| DUSA Pharmaceuticals | 0.7 | $3.4M | 550k | 6.22 | |
| BioScrip | 0.7 | $3.2M | 500k | 6.49 | |
| NPS Pharmaceuticals | 0.6 | $3.0M | 314k | 9.45 | |
| Acelrx Pharmaceuticals | 0.4 | $2.0M | 436k | 4.59 | |
| RTI Biologics | 0.3 | $1.7M | 643k | 2.71 | |
| American Dental Partners | 0.3 | $1.5M | 117k | 12.96 | |
| Nanosphere | 0.3 | $1.5M | 827k | 1.81 | |
| Universal American | 0.3 | $1.5M | 133k | 10.95 | |
| Exelixis (EXEL) | 0.3 | $1.4M | 152k | 8.96 | |
| Celsion Corporation | 0.2 | $1.2M | 358k | 3.37 | |
| D Tranzyme | 0.2 | $1.0M | 246k | 4.18 | |
| Tenet Healthcare Corporation | 0.2 | $980k | 157k | 6.24 | |
| K-V Pharmaceutical Company | 0.2 | $952k | 350k | 2.72 | |
| Orexigen Therapeutics | 0.2 | $875k | 550k | 1.59 | |
| Onyx Pharmaceuticals | 0.2 | $883k | 25k | 35.32 | |
| Tearlab Corp | 0.2 | $783k | 412k | 1.90 | |
| Cleveland BioLabs | 0.1 | $652k | 191k | 3.41 | |
| LCA-Vision | 0.1 | $558k | 117k | 4.78 | |
| Aegerion Pharmaceuticals | 0.1 | $547k | 35k | 15.76 | |
| Allergan | 0.1 | $416k | 5.0k | 83.20 | |
| Cadence Pharmaceuticals | 0.1 | $369k | 40k | 9.20 | |
| ArthroCare Corporation | 0.1 | $238k | 7.1k | 33.52 | |
| Wright Medical | 0.0 | $212k | 14k | 15.00 | |
| Achillion Pharmaceuticals | 0.0 | $118k | 16k | 7.42 | |
| AVANIR Pharmaceuticals | 0.0 | $79k | 23k | 3.37 | |
| Somaxon Pharmaceuticals | 0.0 | $94k | 44k | 2.13 | |
| BSD Medical Corporation | 0.0 | $112k | 27k | 4.10 | |
| Apricus Bioscience | 0.0 | $96k | 20k | 4.80 | |
| USD.001 Ibio | 0.0 | $102k | 36k | 2.86 |
